Quality & complianceOfficial

Polish chief inspector issues notice on reporting suspected medicine quality defects to inspectorate

🇵🇱 GIF (Poland) · Mon 16 Nov 2026

GIF's communication of 16 November 2026 concerns how information on suspected or confirmed quality non-conformity of medicinal products should reach Polish pharmaceutical inspection authorities.

Poland's Chief Pharmaceutical Inspector (GIF) published a communication dated 16 November 2026 on passing information to the bodies of the State Pharmaceutical Inspectorate. The information in question concerns a suspicion or finding that a medicinal product does not meet the quality requirements set for it.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: GIF (Poland) ↗

Article written by VigiEye from the official source (GIF (Poland)). AI-assisted; check the source before acting.